SUSSMAN JOEL F.officer: Chief Accounting Officerofficer: Chief Accounting Officer
Stock Option (Right to Buy)
6,245
$1.75
$10,929
Purchase
ALLEVA LAWRENCE Mdirectordirector
Common Stock
2,325
$10.22
$23,771
Option
SUSSMAN JOEL F.officer: Chief Accounting Officerofficer: Chief Accounting Officer
Common Stock
10,000
N/A
N/A
Option
SUSSMAN JOEL F.officer: Chief Accounting Officerofficer: Chief Accounting Officer
Stock Option (Right to Buy)
6,245
N/A
N/A
Option
SUSSMAN JOEL F.officer: Chief Accounting Officerofficer: Chief Accounting Officer
Stock Option (Right to Buy)
10,000
$1.07
$10,700
Sale
SUSSMAN JOEL F.officer: Chief Accounting Officerofficer: Chief Accounting Officer
Common Stock
10,000
$1.07
$10,700
Option
SUSSMAN JOEL F.officer: Chief Accounting Officerofficer: Chief Accounting Officer
Common Stock
10,000
$1.07
$10,700
Option
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Stock Option
2,244
$2.43
$5,453
Option
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Common Stock
2,244
$2.43
$5,453
Sale
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Common Stock
2,244
$2.43
$5,453
Sale
NOVO HOLDINGS A/S10 percent owner10 percent owner
COMMON STOCK
450,000
$11
$4,950,000
Sale
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Common Stock
10,536
$12
$126,432
Option
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Common Stock
10,536
$1.11
$11,642
Option
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Stock Option
4,904
$1.07
$5,247
Option
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Common Stock
10,536
$1.11
$11,642
Sale
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Common Stock
100
$1.07
$107
Option
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Stock Option
100
$1.07
$107
Option
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Common Stock
100
$1.07
$107
Sale
NOVARTIS BIOVENTURES LTDother: Former 10% Ownerother: Former 10% Owner
Common Stock
1,001,312
$8.25
$8,260,824
Sale
NOVARTIS BIOVENTURES LTDother: Former 10% Ownerother: Former 10% Owner
Common Stock
900
$9.04
$8,136
Sale
NOVARTIS BIOVENTURES LTDother: Former 10% Ownerother: Former 10% Owner
Common Stock
4,622
$9.27
$42,846
Sale
NOVARTIS BIOVENTURES LTDother: Former 10% Ownerother: Former 10% Owner
Common Stock
8,600
$9.3
$79,980
Sale
NOVARTIS BIOVENTURES LTDother: Former 10% Ownerother: Former 10% Owner
Common Stock
6,164
$9.05
$55,784
Sale
NOVARTIS BIOVENTURES LTDother: Former 10% Ownerother: Former 10% Owner
Common Stock
1,500
$9.19
$13,785
Sale
NOVARTIS BIOVENTURES LTDother: Former 10% Ownerother: Former 10% Owner
Common Stock
7,200
$9.21
$66,312
Sale
NOVARTIS BIOVENTURES LTDother: Former 10% Ownerother: Former 10% Owner
Common Stock
8,532
$9.46
$80,713
Sale
NOVARTIS BIOVENTURES LTDother: Former 10% Ownerother: Former 10% Owner
Common Stock
7,000
$9.38
$65,660
Sale
NOVARTIS BIOVENTURES LTDother: Former 10% Ownerother: Former 10% Owner
Common Stock
5,659
$9.66
$54,666
Sale
NOVARTIS BIOVENTURES LTDother: Former 10% Ownerother: Former 10% Owner
Common Stock
8,652
$9.66
$83,578
Sale
NOVARTIS BIOVENTURES LTDother: Former 10% Ownerother: Former 10% Owner
Common Stock
4,088
$9.55
$39,040
Sale
NOVARTIS BIOVENTURES LTDother: Former 10% Ownerother: Former 10% Owner
Common Stock
5,208
$9.78
$50,934
Sale
NOVARTIS BIOVENTURES LTDother: Former 10% Ownerother: Former 10% Owner
Common Stock
5,669
$9.68
$54,876
Option
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Common Stock
692
$1.07
$740
Sale
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Common Stock
692
$1.07
$740
Option
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Stock Option
692
$1.07
$740
Sale
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Common Stock
1,174
$12
$14,088
Option
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Common Stock
1,174
$12
$14,088
Option
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Stock Option
1,174
$12
$14,088
Option
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Stock Option
969
$1.07
$1,037
Option
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Common Stock
969
$1.07
$1,037
Sale
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Common Stock
969
$1.07
$1,037
Option
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Common Stock
671
$12
$8,052
Sale
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Common Stock
671
$12
$8,052
Option
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Stock Option
671
$12
$8,052
Option
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Common Stock
185
$12
$2,220
Sale
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Common Stock
185
$12
$2,220
Option
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Stock Option
185
$12
$2,220
Option
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Stock Option
5,102
$1.07
$5,459
Option
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Common Stock
5,102
$1.07
$5,459
Sale
HOLMLUND JON Tofficer: Chief Medical Officerofficer: Chief Medical Officer
Common Stock
5,102
$1.07
$5,459
Showing 50 to 100 of 116 results.
Insider trading
Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.
Who is insider?
Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.